Pursuant to Rule 20 of the Companies (Management and Administration) Rules, 2014, Ganga Pharmaceuticals has published an advertisement in the Financial Express (English) and Mumbai Lakshadeep (Marathi) newspaper on September 02, 2022 about completion of dispatch of Notice and Annual Report and details pertaining to e-voting. Pursuant to Regulation 30 read with 47 of the SEBI (LODR) Regulations, 2015, the Company has informed that it enclosed copies of newspaper advertisements published on September 02, 2022 in ‘Financial Express’ (English) and ‘Mumbai Lakshadeep’ (Marathi), regarding the Notice of the 33 Annual General Meeting of the Company to be held on Saturday, September 24, 2022 at 12:30 pm (IST) at the registered office of the Company at Gangatat, Dhanvantri Marg, Gopcharpada, Virar (E), Palghar- 401305. The aforesaid information has also been uploaded on the website of the Company at www.ayurvedganga.com.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: